Last reviewed · How we verify

NCT05086679: COMFORTS II

Compression Stockings for Treating Vasovagal Syncope Trial

Status unknown NA Last updated 15 April 2022
What this trial tests

NA trial testing Compression Stockings with 25-30 mm Hg pressure in Syncope, Vasovagal in 268 participants. Status unknown.

Timeline
14 March 2022
Primary endpoint
10 October 2024
10 December 2024

Quick facts

Lead sponsorTehran Heart Center
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposetreatment
Enrollment268
Start date14 March 2022
Primary completion10 October 2024
Estimated completion10 December 2024
Sites1 location across Iran

Drugs / interventions tested

Conditions studied

Sponsor

Tehran Heart Center — full company profile →

Who can join

Adults 18 to 65, any sex, with Syncope, Vasovagal. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Syncope, a sudden, transient loss of consciousness (TLOC), is a common inconvenience of daily function and quality of life (QoL). The vasovagal syncope (VVS) is the most common type of syncope, which central and peripheral stimuli may trigger syncope by decreasing peripheral vascular resistance, bradycardia, or both. The venous return to the heart is one of these triggers which its reduction may occur due to prolonged standing, hot environment, hypovolemia, or redistribution of blood volume. The compression stockings may reduce syncopal episodes by increasing venous return. Although the use of compression stockings was never assessed in clinical trials, it could be a possible treatment for decreasing VVS recurrences.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Syncope, Vasovagal

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05086679.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing